Filing Details

Accession Number:
0001181431-11-004332
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-01-20 08:33:35
Reporting Period:
2011-01-18
Filing Date:
2011-01-20
Accepted Time:
2011-01-20 08:33:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1135906 Zalicus Inc. ZLCS Pharmaceutical Preparations (2834) 043514457
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1250661 Mark Corrigan C/O Zalicus Inc.
245 First Street, 3Rd Floor
Cambridge MA 02142
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-01-18 62,160 $2.18 775,045 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2010 and were to satisfy statutory tax withholding requirements upon vesting of restricted stock units.